PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsovarian neoplasms
MeSH D010051 - ovarian neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D005833:Female genital neoplasms
0 Companies
0 Drugs
Success rate
D004701:Endocrine gland neoplasms
0 Companies
0 Drugs
Success rate
D010049:Ovarian diseases
0 Companies
0 Drugs
Success rate
D010051: 
Ovarian neoplasms
D000077216:Ovarian epithelial carcinoma
$
Success rate
D001948:Brenner tumor
0 Companies
0 Drugs
Success rate
D006106:Granulosa cell tumor
0 Companies
0 Drugs
Success rate
D008539:Meigs syndrome
0 Companies
0 Drugs
Success rate
D013798:Thecoma
0 Companies
0 Drugs
Success rate
D018269:Endometrioid carcinoma
0 Companies
0 Drugs
Success rate
D018310:Sertoli-leydig cell tumor
0 Companies
0 Drugs
Success rate
D018311:Luteoma
0 Companies
0 Drugs
Success rate
D061325:Hereditary breast and ovarian cancer syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AbbVieLeuprolide, Norethindrone Lupaneta Pack  2012-12-14   
Leuprolide Lupron  1985-04-09 $783 M Y2021 
Leuprolide Lupron Depot  1989-01-26   
Leuprolide Lupron Depot-ped 2028-03-22 1993-04-16   
Accord HealthcareLeuprolide Camcevi 2027-01-16 2021-05-25   
Carboplatin Carboplatin  2017-02-09   
Docetaxel Docetaxel  2011-06-08   
Docetaxel Docetaxel Accord  2012-05-22   
Gemcitabine Gemcitabine  2011-07-25   
Oxaliplatin Oxaliplatin  2017-03-21   
Paclitaxel Paclitaxel  2004-11-12   
Topotecan Topotecan  2013-06-26   
Doxorubicin Zolsketil pegylated  2022-05-31   
Cisplatin Cisplatin  2015-08-18   
Acrotech BiopharmaMelphalan Evomela 2029-03-13 2016-03-10   
AdienneMelphalan Phelinun  2020-11-16   
Thiotepa Tepadina  2017-01-26   
Alembic PharmaceuticalsCyclophosphamide Cyclophosphamide  2022-11-10   
Paclitaxel Paclitaxel  2022-10-20   
Docetaxel Docetaxel  2023-02-28   
AllerganCarboplatin Carboplatin  2004-10-14   
Docetaxel Docetaxel  2013-04-12   
Doxorubicin Doxorubicin  2014-06-27   
Gemcitabine Gemcitabine  2011-07-25   
Melphalan Melphalan  2016-12-19   
Oxaliplatin Oxaliplatin  2012-08-08   
Paclitaxel Paclitaxel  2009-12-09   
Topotecan Potactasol  2011-01-06   
Topotecan Topotecan  2010-12-02   
Topotecan Topotecan Actavis  2009-07-24   
Vinorelbine Vinorelbine  2009-07-22   
AlvogenMelphalan Melphalan  2017-03-22   
American RegentGemcitabine Gemcitabine  2013-05-07   
Oxaliplatin Oxaliplatin  2017-05-12   
Paclitaxel Paclitaxel  2022-07-27   
AmgenBevacizumab Mvasi  2017-09-14   
Amneal PharmaceuticalsBevacizumab Alymsys  2022-04-13   
Cyclophosphamide Cyclophosphamide  2018-05-25   
Docetaxel Docetaxel  2018-01-19   
Doxorubicin Doxorubicin  2017-02-17   
Leuprolide Leuprolide  2022-10-28   
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
75%
182/243
Phase 2
25%
74/296
Phase 3
37%
49/133
Approved: 31Overall Success rate: 7%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
1
2
3
4
5
6
7
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use